Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Non Insulin Dependent Oral Agent Therapy”

Showing 14 of 0 results

Large-scale testing (Phase 3)Study completedNCT01706211
What this trial is testing

Evaluate the Efficacy and Safety of BRL 49653C in Non-insulin Dependent Diabetes

Who this might be right for
Diabetes Mellitus Non Insulin Dependent Oral Agent Therapy
National Taiwan University Hospital 77
Large-scale testing (Phase 3)Study completedNCT00819091
What this trial is testing

Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 245
Large-scale testing (Phase 3)Study completedNCT01431807
What this trial is testing

Long-term Study of SYR-472

Who this might be right for
Diabetes Mellitus
Takeda 680
Post-approval studies (Phase 4)Study completedNCT00686634
What this trial is testing

Sitagliptin in Combination With Metformin and Sulfonylurea

Who this might be right for
Type 2 Diabetes Mellitus
Charles Drew University of Medicine and Science 108
Large-scale testing (Phase 3)Study completedNCT03175120
What this trial is testing

A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 453
Testing effectiveness (Phase 2)Study completedNCT06199505
What this trial is testing

A Trial Comparing Efficacy and Safety of GZR101 and IDegAsp in Insulin Naïve or Insulin Treated Subjects with T2DM

Who this might be right for
Type 2 Diabetes
Gan and Lee Pharmaceuticals, USA 153
Early research (Phase 1)Study completedNCT07266766
What this trial is testing

Bioequivalence Study to Compare Empagliflozin / Metformin 25 mg/ 1000 mg Extended-Release Tablet Versus Synjardy XR Tablets 25mg/1000mg

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Humanis Saglık Anonim Sirketi 40
Large-scale testing (Phase 3)Ended earlyNCT01829477
What this trial is testing

Comparison of TAK-875 to Placebo as an Add-on to Glimepiride in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 33
Not applicableStudy completedNCT01219582
What this trial is testing

GLucobay M OBservation Study for Efficacy and Safety in Treatment of Type-2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Bayer 9,364
Large-scale testing (Phase 3)Ended earlyNCT01829464
What this trial is testing

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

Who this might be right for
Diabetes
Takeda 90
Large-scale testing (Phase 3)Ended earlyNCT00391196
What this trial is testing

A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

Who this might be right for
Obesity
Pfizer 975
Early research (Phase 1)Study completedNCT06124495
What this trial is testing

Bioequivalence Study of Sitagliptin Hydrochloride / Metformin Hydrochloride Extended-release Film Coated Tablets 50 mg /500 mg (FDC) in Healthy Adult Male and Female Subjects Under Fasting Conditions.

Who this might be right for
BioequivalenceDiabetes Mellitus, Type 2
Galenicum Health 58
Large-scale testing (Phase 3)WithdrawnNCT07057479
What this trial is testing

Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)
Eurofarma Laboratorios S.A.
Large-scale testing (Phase 3)Study completedNCT01368081
What this trial is testing

Empagliflozin (BI 10773) Comprehensive add-on Study in Japanese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 1,162

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation